GAFFX
Price
$76.01
Change
+$0.28 (+0.37%)
Updated
May 22 closing price
Net Assets
297.16B
PBLCX
Price
$41.16
Change
+$0.04 (+0.10%)
Updated
May 22 closing price
Net Assets
11B
Interact to see
Advertisement

GAFFX vs PBLCX

Header iconGAFFX vs PBLCX Comparison
Open Charts GAFFX vs PBLCXBanner chart's image
American Funds Growth Fund of Amer F3
Price$76.01
Change+$0.28 (+0.37%)
VolumeN/A
Net Assets297.16B
Principal Blue Chip C
Price$41.16
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets11B
GAFFX vs PBLCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. PBLCX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and PBLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 297B vs. PBLCX (11B). GAFFX pays higher dividends than PBLCX: GAFFX (0.70) vs PBLCX (0.00). GAFFX was incepted earlier than PBLCX: GAFFX (8 years) vs PBLCX (12 years). PBLCX (1.69) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. PBLCX (14.70). PBLCX has a lower initial minimum investment than GAFFX: PBLCX (1000) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 6.73 vs. PBLCX (5.71). PBLCX return over 5 years is better than : 58.89 vs. GAFFX (49.43).
GAFFXPBLCXGAFFX / PBLCX
Total Expense Ratio0.301.6618%
Annual Report Gross Expense Ratio0.301.6918%
Fund Existence8 years12 years-
Gain YTD2.0682.46784%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets297B11B2,700%
Annual Yield % from dividends0.700.00-
Returns for 1 year6.735.71118%
Returns for 3 years40.7453.8376%
Returns for 5 years49.4358.8984%
Returns for 10 yearsN/A155.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRAW1.260.06
+5.00%
Traws Pharma Inc
FOXA55.14N/A
N/A
Fox Corp
PTGX45.82N/A
N/A
Protagonist Therapeutics
LASR13.45N/A
N/A
nLIGHT
HITI2.30N/A
N/A
High Tide